CGON CG Oncology Inc Gross Return on Sales

CGON (CG Oncology Corp) - company brandmark

A stable geopolitical environment supports the development of CG Oncology, Inc. (CGON), as evidenced by the gross profit margin dynamics within revenue, where -106.20 indicates the value of this parameter. However, the business remains vulnerable due to its reliance on external financing and the risks of clinical failures. This situation is mitigated by a strategic focus on bladder cancer therapy covering various stages of the disease.

CG Oncology Corp (CGON): Gross Profitability from 02/21/2024 to 11/20/2026

Analytical breakdowns and data insights for company CG Oncology Inc (CGON)

- stock value and consensus price forecast:
- cash and cash flow statistics:
Fundamental valuation:CGON (CG Oncology Corp)
Finished products of CG Oncology

To minimize investment risks, it is necessary to evaluate the efficiency of direct cost management by analyzing the revenue share remaining after deducting the cost of goods sold. By examining the history of gross margins, an investor determines the ability of CG Oncology, Inc. (CGON) to convert demand for innovative cancer therapy into net profit, which confirms the business's transition to a stage of stable high liquidity generation.

Key competitors

Gross Profit Margin BeiGene Ltd. (ONC)|Return on Gross Profit HALO|Gross Profitability RVMD|Return on Gross Profit AAPG (Ascentage)|UroGen Pharma - Gross Return on Sales|Bicara Therapeutics - Return on Gross Profit|Gross Margin Personalis Inc PSNL|Erasca Oncology - Gross Margin|Gross Profit Rate DCTH (Delcath Corp)|YMAB: Gross Margin|AURA - Return on Sales by Gross Profit|CADL (Candel Therapeutics Inc.) - Gross Margin|Gross Return on Sales ARAY (Accuray)|Return on Gross Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Gross Profit Margin|Gross Profitability Citius Oncology, Inc. CTOR|HURA - Return on Gross Profit|protaratx.com - Gross Margin|FATE - Gross Margin|WHWK: Gross Margin|TScan Therapeutics (TCRX) - Gross Margin|Gross Profitability Champions Oncology|Gross Profitability XBIT|Gross Margin CVM|Return on Gross Profit OS Therapies Inc. OSTX|Gross Profitability Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Gross Profit Margin|ANL - Gross Profitability|Gross Profit Margin verupharma.com|TPST: Gross Margin|XLO - Return on Sales by Gross Profit|Gross Profitability Renovaro|Gross Margin muraloncology.com|Gross Margin KAPA|Return on Sales by Gross Profit OnKure Therapeutics, Inc.|Gross Margin GDTC (w2.cytomed.sg)|CRIS - Return on Gross Profit|Apollomics - Gross Margin|Tharimmune Corp (THAR) - Return on Gross Profit|ADVB: Gross Margin|Return on Gross Profit Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Gross Margin|Gross Return on Sales SBFM (Sunshine Biopharma)|Gross Profitability Xenetic Bio (XBIO)|Gross Profitability SLRX (Salarius Pharma)|Kitov Pharma - Return on Gross Profit|American Oncology Network (AONC) - Gross Profit Margin|BeiGene - Gross Margin|Checkpoint Therapeutics, Inc. (CKPT) - Return on Gross Profit|ELEV (Elevation Oncology, Inc.) - Return on Gross Profit|iCAD Inc. - Gross Profit Rate|Return on Gross Profit IKNA|Gross Margin notablelabs.com|Return on Gross Profit VIRX (Viracta Therapeutics Inc.)|MOR - Gross Profit Margin|Gross Profitability NAYA Biosciences NAYA|AAPGV - Return on Gross Profit